Open AccessAdherence with the standard treatment regimen for the treatment of COVID-19 patients in Bangabandhu Sheikh Mujib Medical University
Author(s) -
Elora Sharmin,
Sharmeen Ahmed,
Ruhul Amin,
Nazmul Hasan,
Sayeda Papia,
Sharmeen Ahmed,
Rezwanul Quader
Publication year - 2021
Publication title -
bangabandhu sheikh mujib medical university journal
Language(s) - English
Resource type - Journals
eISSN - 2224-7750
pISSN - 2074-2908
DOI - 10.3329/bsmmuj.v14i3.54675
Subject(s) - medicine , guideline , regimen , covid-19 , asthma , diabetes mellitus , cross sectional study , physical therapy , pediatrics , disease , infectious disease (medical specialty) , pathology , endocrinology
The present study was conducted to evaluate the adherence to standard treatment regimen in Bangabandhu Sheikh Mujib Medical University (BSMMU) for the treatment of corona virus disease 19 (COVID-19) patients. The study assessed the awareness of prescribers, adherence to treatment guidelines and reasons for non-adherence. A questionnaire survey was conducted followed by a retrospective and prospective medical review and in-depth interview. The study revealed that 79.9% of key prescribers are aware of treatment guidelines. Adherence was 28.4% in moderate cases and 53.3% in severe cases and difference was highly statistically significant (p<0.001). Adherence in moderate cases was highest in patients with hypertension (43.3%) and lowest in bronchial asthma (16.6%). Adherence in severe cases was highest with diabetes (80%) and lowest in bronchial asthma (20 %). In COVID-19 patients, the adherence was highest with International Guideline (96%), followed by institutional Guideline (74.6%) and National Guideline (23.5%). There is significant variation in extent of adherence in different age group of patients, co-morbidities and categories of guidelines.
BSMMU J 2021; 14 (COVID -19 Supplement): 13-18